MarketPeel
Insider Trading Intelligence
SH

Steven L. Hoerter

MBX
DIRECTOR · MBX BIOSCIENCES, INC. · CIK 0001533451
FILING MIX · LIFETIME100%/0%
BUYS
19
SELLS
0
TOTAL VALUE
$265.0K
COMPANIES
3
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
114,500
AVG SELL PX
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Steven L. Hoerter, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+28.59%+1.94%+26.66%+26.66%
14d1+100.00%+66.11%+2.66%+63.45%+63.45%
30d1+100.00%+93.72%+0.19%+93.53%+93.53%
60d1+100.00%+109.91%+2.18%+107.73%+107.73%
90d1+100.00%+209.46%+4.19%+205.26%+205.26%
180d1+100.00%+149.32%+5.35%+143.97%+143.97%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MBX · 12,500 shares · as of Jun 4, 2026
025,00050,00075,000100,0002026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 0 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CCCC
C4 THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
62,00062,000Jun 24, 2026Jun 26, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
12,50012,500Jun 4, 2026Jun 5, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
74,24974,249May 1, 2026May 4, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
11,93811,938May 1, 2026May 4, 2026View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jan 2, 2026Jan 6, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
8,0008,000Nov 22, 2025Nov 25, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
00Nov 22, 2025Apr 22, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
100,000100,000Nov 6, 2025Nov 7, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
33,75133,751Nov 6, 2025Apr 22, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
20,000$13.25$265.0K20,000Oct 17, 2025Oct 20, 2025View →
CCCC
C4 THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
35,50035,500Jun 18, 2025Jun 20, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
16,00016,000Jun 5, 2025Jun 6, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
32,00032,000Apr 7, 2025Apr 9, 2025View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,00035,000Jan 2, 2025Jan 6, 2025View →
CCCC
C4 THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
65,00065,000Nov 19, 2024Nov 21, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,60025,600Jun 12, 2024Jun 14, 2024View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,50020,500Jun 14, 2023Jun 15, 2023View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
50,28350,283Jun 17, 2022Jun 17, 2022View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
33,25033,250Aug 13, 2021Aug 16, 2021View →
Other insiders · MBX
Loading peer insiders…
About this filer
CIK 0001533451
ROLE
Director
PRIMARY
MBX
COMPANIES
3
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001533451DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback